Pier Capital’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-64,094	Closed	-$4.47M	–	115
2020 Q2	$4.47M	Buy	+64,094	New	+$4.47M	0.72%	85